Wolverine Trading, LLC Biocryst Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $36,537 - $49,533	-5,700 Reduced 12.31%	40,600 $308,000
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $91,273 - $150,059	22,100 Added 91.32%	46,300 $286,000
Q1 2024 May 15, 2024	SELL	$4.89 - $7.65 $1.06 Million - $1.66 Million	-216,600 Reduced 89.95%	24,200 $122,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $378,978 - $515,196	76,100 Added 46.21%	240,800 $1.44 Million
Q3 2023 Nov 15, 2023	BUY	$6.71 - $7.92 $501,237 - $591,624	74,700 Added 83.0%	164,700 $1.17 Million
Q2 2023 Aug 23, 2023	SELL	$6.96 - $8.81 $88,392 - $111,887	-12,700 Reduced 12.37%	90,000 $633,000
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $815,438 - $1.22 Million	102,700 New	102,700 $862,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $549,211 - $753,829	50,900 Added 32.9%	205,600 $2.54 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $285,618 - $647,256	-36,200 Reduced 18.96%	154,700 $1.67 Million
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $2.21 Million - $3.77 Million	190,900 New	190,900 $3.14 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $2.68 Million - $3.71 Million	-239,900 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $1.27 Million - $1.58 Million	89,700 Added 59.72%	239,900 $3.45 Million
Q2 2021 Aug 06, 2021	BUY	$9.5 - $17.24 $848,350 - $1.54 Million	89,300 Added 146.63%	150,200 $2.33 Million
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $51,590 - $95,270	-7,000 Reduced 10.31%	60,900 $608,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $165,467 - $422,751	49,100 Added 261.17%	67,900 $509,000
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $83,349 - $134,379	-24,300 Reduced 56.38%	18,800 $72,000
Q2 2020 Aug 13, 2020	SELL	$1.9 - $5.61 $32,110 - $94,809	-16,900 Reduced 28.17%	43,100 $215,000
Q1 2020 May 11, 2020	BUY	$1.6 - $4.11 $24,000 - $61,650	15,000 Added 33.33%	60,000 $119,000
Q4 2019 Feb 12, 2020	BUY	$1.59 - $3.45 $27,507 - $59,685	17,300 Added 62.45%	45,000 $145,000
Q3 2019 Nov 14, 2019	BUY	$2.5 - $3.73 $13,000 - $19,396	5,200 Added 23.11%	27,700 $88,000
Q2 2019 Aug 20, 2019	BUY	$2.91 - $9.15 $65,475 - $205,875	22,500 New	22,500 $85,000
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $138,006 - $181,764	-18,700 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.51 - $9.6 $55,986 - $82,560	-8,600 Reduced 31.5%	18,700 $147,000
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $150,696 - $218,127	27,300 New	27,300 $208,000
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $188,032 - $240,916	-45,200 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.1 - $5.97 $185,319 - $269,844	45,200	45,200 $237,000

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$152 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$90.2 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.3 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account